CD8+ TIL Recruitment May Revert the Association of MAGE A3 with Aggressive Features in Thyroid Tumors
Table 1
MAGE A3 expression levels according to visual (semiquantitative) IHC in benign and malignant thyroid nodules and in different follicular patterned lesions including classic (CPTC), follicular variant papillary thyroid carcinomas (FVPT), follicular carcinoma (FTC), and follicular adenoma (FA).